Literature DB >> 12732258

Regional brain cytochrome oxidase activity in beta-amyloid precursor protein transgenic mice with the Swedish mutation.

C Strazielle1, C Sturchler-Pierrat, M Staufenbiel, R Lalonde.   

Abstract

Cytochrome oxidase activity was examined in a transgenic mouse model of Alzheimer's disease with overexpression of the 751 amino acid isoform of beta-amyloid precursor protein with the Swedish mutation under control of the murine thy-1 promoter. The neuritic plaques, abundantly localized in the hippocampus and anterior neocortical areas, showed a core devoid of enzymatic activity surrounded by higher cytochrome oxidase activity at the sites of the dystrophic neurites and activated glial cells. Quantitative measures, taken only in the healthy-appearing regional areas without neuritic plaques, were higher in numerous limbic and non-limbic regions of transgenic mice in comparison with controls. Enzymatic activity was higher in the dentate gyrus and CA2-CA3 region of the hippocampus, the anterior cingulate and primary visual cortex, two olfactory structures, the ventral part of the neostriatum, the parafascicularis nucleus of the thalamus, and the subthalamic nucleus. Brainstem regions anatomically related with altered forebrain regions were more heavily labeled as well, including the substantia nigra, the periaqueductal gray, the superior colliculus, the medial raphe, the locus coeruleus and the adjacent parabrachial nucleus, as well as the pontine nuclei, red nucleus, and trigeminal motor nucleus. Functional brain organization is discussed in the context of Alzheimer's disease. Although hypometabolism is generally observed in this pathology, the increased cytochrome oxidase activity obtained in these transgenic mice can be the result of a functional compensation on the surviving neurons, or of an early mitochondrial alteration related to increased oxidative damage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12732258     DOI: 10.1016/s0306-4522(03)00037-x

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  10 in total

1.  Regional brain variations of cytochrome oxidase activity in spontaneously hypertensive mice.

Authors:  C Strazielle; R Lalonde; S Thifault; P Hamet
Journal:  Exp Brain Res       Date:  2004-03-06       Impact factor: 1.972

2.  Energy metabolism is compromised in skeletal muscle of rats chronically-treated with glutaric acid.

Authors:  Gustavo da C Ferreira; Patrícia F Schuck; Carolina M Viegas; Anelise Tonin; Alexandra Latini; Carlos S Dutra-Filho; Angela T S Wyse; Clóvis M D Wannmacher; Carmen R Vargas; Moacir Wajner
Journal:  Metab Brain Dis       Date:  2007-01-13       Impact factor: 3.584

Review 3.  A generic research paradigm for identification and validation of early molecular diagnostics and new therapeutics in common disorders.

Authors:  Keith D Coon; Travis L Dunckley; Dietrich A Stephan
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

4.  Induction of apoptotic change in the rat hippocampus caused by ferric nitrilotriacetate.

Authors:  Shigeru Maeda; Yukiko Arai; Hitoshi Higuchi; Yumiko Tomoyasu; Ryuichiro Mizuno; Toru Takahashi; Takuya Miyawaki
Journal:  Redox Rep       Date:  2011       Impact factor: 4.412

5.  Behavioral changes and mitochondrial dysfunction in a rat model of schizophrenia induced by ketamine.

Authors:  Larissa de Oliveira; Daiane B Fraga; Renata D De Luca; Leila Canever; Fernando V Ghedim; Maria Paula P Matos; Emilio L Streck; João Quevedo; Alexandra I Zugno
Journal:  Metab Brain Dis       Date:  2011-02-18       Impact factor: 3.584

6.  Evaluation of respiratory chain activity in lymphocytes of patients with Alzheimer disease.

Authors:  Pollyana Feldhaus; Daiane B Fraga; Fernando V Ghedim; Renata D De Luca; Thiago D Bruna; Matheus Heluany; Maria Paula Matos; Gabriela K Ferreira; Isabela C Jeremias; Claudia Heluany; Emilio L Streck; Alexandra I Zugno
Journal:  Metab Brain Dis       Date:  2011-07-26       Impact factor: 3.584

7.  Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairment.

Authors:  Jon Valla; Lonnie Schneider; Tracy Niedzielko; Keith D Coon; Richard Caselli; Marwan N Sabbagh; Geoffrey L Ahern; Leslie Baxter; Gene Alexander; Douglas G Walker; Eric M Reiman
Journal:  Mitochondrion       Date:  2006-10-27       Impact factor: 4.160

8.  Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage.

Authors:  Maria Manczak; Byung S Park; Youngsin Jung; P Hemachandra Reddy
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

9.  Early-onset dysfunction of retrosplenial cortex precedes overt amyloid plaque formation in Tg2576 mice.

Authors:  G L Poirier; E Amin; M A Good; J P Aggleton
Journal:  Neuroscience       Date:  2010-11-18       Impact factor: 3.590

10.  Prophylactic melatonin significantly reduces Alzheimer's neuropathology and associated cognitive deficits independent of antioxidant pathways in AβPP(swe)/PS1 mice.

Authors:  G O'Neal-Moffitt; V Delic; P C Bradshaw; J Olcese
Journal:  Mol Neurodegener       Date:  2015-07-11       Impact factor: 14.195

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.